William Blair Investment Management’s Bloomin' Brands BLMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,649,084
Closed -$20.1M 429
2024
Q4
$20.1M Buy
1,649,084
+18,525
+1% +$266K 0.05% 308
2024
Q3
$27M Buy
1,630,559
+188,890
+13% +$3.35M 0.07% 261
2024
Q2
$27.7M Sell
1,441,669
-3,621
-0.3% -$84.9K 0.07% 241
2024
Q1
$41.5M Sell
1,445,290
-144,249
-9% -$3.92M 0.11% 176
2023
Q4
$44.7M Sell
1,589,539
-30,964
-2% -$752K 0.13% 150
2023
Q3
$39.8M Sell
1,620,503
-120,995
-7% -$3.21M 0.13% 154
2023
Q2
$46.8M Buy
1,741,498
+32,016
+2% +$802K 0.15% 140
2023
Q1
$43.8M Buy
1,709,482
+4,909
+0.3% +$122K 0.15% 139
2022
Q4
$34.3M Sell
1,704,573
-64,305
-4% -$1.39M 0.13% 166
2022
Q3
$32.4M Sell
1,768,878
-36,739
-2% -$730K 0.13% 165
2022
Q2
$30M Sell
1,805,617
-54,067
-3% -$1.1M 0.11% 207
2022
Q1
$40.8M Sell
1,859,684
-308,560
-14% -$6.65M 0.12% 182
2021
Q4
$45.5M Buy
+2,168,244
New +$45.8M 0.12% 177

Other funds holding BLMN

William Blair Investment Management's BLMN Position: Q1 2025 in Review

William Blair Investment Management sold out of Bloomin' Brands (BLMN) in Q1 2025, closing a stake of 1,649,084 shares — an estimated $20.1M sold.

William Blair Investment Management first reported a position in BLMN in Q4 2021 and held it in 13 quarters. The position peaked at $46.8M in Q2 2023. 242 funds tracked by Wall St. Rank hold BLMN as of Q1 2025.

  • William Blair Investment Management reported no remaining Bloomin' Brands position as of Q1 2025 after selling out during the quarter.
  • William Blair Investment Management sold 1,649,084 Bloomin' Brands shares in Q1 2025, an estimated $20.1M.
  • William Blair Investment Management first reported a position in Bloomin' Brands in Q4 2021 and held it in 13 quarters.
  • William Blair Investment Management's Bloomin' Brands position peaked at $46.8M in Q2 2023.
  • 242 funds tracked by Wall St. Rank held Bloomin' Brands as of Q1 2025.

Based on William Blair Investment Management's 13F filing for Q1 2025, filed 9 May 2025.